Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Merozoite Surface Protein 3 is an exposed soluble protein complexed on P. falciparum’s invasive stage. It binds heme via amyloid-like structures, interacts closely with other major merozoite antigens through its N-terminal domain, serves as an important target for host immune responses—especially at its C terminus—and remains under active investigation both functionally and as part of next-generation malaria vaccines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Merozoite Surface Protein 3.